| Literature DB >> 18432888 |
Angus Lauder1, Andrew N J McKenzie.
Abstract
This unit describes two protocols that can be used to quantitate interleukin-13 (IL-13). The enzyme-linked immunosorbent assay (ELISA) has the advantage of being highly specific for human IL-13 and does not recognize other cytokines present in the sample. A bioassay is also presented based on the ability of IL-13 to stimulate the growth of the B9 plasmacytoma cell line. The bioassay method can be used to detect both mouse and human IL-13. B9 cells are dependent on IL-6 for growth and will also respond to IL-4. Thus, although B9 cells can readily be used to quantify IL-13 in the absence of other cytokines, neutralizing antibodies must be incorporated into the bioassay when other cytokines are present in the sample.Entities:
Mesh:
Substances:
Year: 2002 PMID: 18432888 DOI: 10.1002/0471142735.im0618s46
Source DB: PubMed Journal: Curr Protoc Immunol ISSN: 1934-3671